pre-seed
Stage
1
Investors
About
Pephexia Therapeutics is a Danish biotechnology company developing peptide-based pharmacotherapies to treat cachexia, sarcopenia and related wasting disorders. Their lead program includes a clinical candidate PEP-366 in non-clinical development for cancer-associated cachexia.
Explore Pephexia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.